Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (31)
Inflammation and immunity (52)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
20 years of value creation
18 June 2018
Both drivers – curiosity and business potential – are imperative to conducting leading-edge science with long-term societal impacts
Starting a new biotech venture: embarking on a long-term adventure
18 June 2018
“Our job? Working together with world class scientists, seasoned managers and blue chip investors to bring value to society.” This is how our New Ventures team clears the path for the key ingredients of a successful VIB spin-off.
Pioneer or PhD: The spin-off success story of Luc Maertens
18 June 2018
Luc Maertens, currently CEO of agro-biotech firm AgroSavfe, followed Thierry Bogaert to Devgen and became a pioneer in turning disruptive technologies into innovative products and bringing them to the market.
Geert Noels: "unlock flanders’ biotech potential by investing in the very young"
18 June 2018
What if … VIB hadn’t been founded more than 20 years ago? According to economist and author Geert Noels, the answer is simple: we probably wouldn’t have the thriving biotech ecosystem we know today. But that’s no reason to rest on our laurels.
The building blocks of Cutting-edge biotech: how infrastructure drives VIB researchers and entrepreneurs forward
18 June 2018
Access to adequate infrastructure plays a crucial part in VIB’s impact and stature. In recent years, modern facilities that are fully-equipped for top-notch science have allowed our researchers to advance their fields with international acclaim.
Human and artificial intelligence join forces to study complexity of the brain
14 June 2018
A team of scientists lead by Stein Aerts (VIB-KU Leuven) is the first to map the gene expression of each individual brain cell during aging, though they started small: with the brain of a fruit fly.
Gene editing just got easier
8 June 2018
Toon Swings and Jan Michiels (VIB-KU Leuven) together with David Marciano (Baylor College of Medicine) and an international team of researchers have made CRISPR technology more accessible and standardized by simplifying its complex implementation.
Sleep problems in Parkinson’s disease: can we fix them?
7 June 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson’s disease suffer from sleep disturbances.
Working in a VIB start-up
7 June 2018
“It has always been a great experience to bring fundamental research results into practice through a spin-off company."
Unlocking the genome
4 June 2018
A team led by Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells. These findings shed new light on biological mechanisms of gene regulation & open up potential new avenues for cellular reprogramming
How did human brains get so large?
31 May 2018
The human brain is a remarkable organ, but how did it evolve to give us such unprecedented cognitive abilities? The research team of Pierre Vanderhaeghen (ULB, VIB-KU Leuven) turned to the genome for answers.
Verge Genomics Announces Landmark Effort to Generate Field’s First Single Cell Data from Patients with Parkinson’s disease
21 May 2018
In partnership with UC San Diego and VIB, Verge Genomics is leading an industry-academic consortium that will be the first to sequence gene expression in Parkinson’s patient brains at single cell resolution.
Evaluation of the innovative biomolecular analysis tool from FOx Biosystems initiated at the VIB research institute
15 May 2018
FOx Biosystems, a biosensor company, and VIB announced today that VIB will become an important research institute to evaluate the White FOx 1.0 in its workflows as part of its vision for adopting breakthrough technologies.
VIB scientists Jenny Russinova and Patrik Verstreken elected as EMBO Members
15 May 2018
EMBO elected 62 outstanding life scientists to its membership, joining a group of more than 1800 of the best researchers in Europe and around the world.
Alzheimer’s antibody developed by VIB goes US
12 May 2018
VIB has signed an exclusive license & collaboration agreement with new-kid-on-the-stock-market Denali Therapeutics. The biotech company specializes in treating neurodegenerative diseases through rigorous therapeutic discovery and development
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next»
Page Content Zone 2
Page Content Zone 3